7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer's Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies Article

Spilovska, Katarina, Korabecny, Jan, Kral, Jan et al. (2013). 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer's Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies . MOLECULES, 18(2), 2397-2418. 10.3390/molecules18022397

Open Access International Collaboration

cited authors

  • Spilovska, Katarina; Korabecny, Jan; Kral, Jan; Horova, Anna; Musilek, Kamil; Soukup, Ondrej; Drtinova, Lucie; Gazova, Zuzana; Siposova, Katarina; Kuca, Kamil

sustainable development goals

authors

publication date

  • February 1, 2013

published in

keywords

  • 7-MEOTA
  • ACETYLCHOLINESTERASE INHIBITORS
  • AMYLOID AGGREGATION
  • Alzheimer's disease
  • Biochemistry & Molecular Biology
  • CHOLINERGIC HYPOTHESIS
  • Chemistry
  • Chemistry, Multidisciplinary
  • DRUG
  • DUAL INHIBITORS
  • IN-VITRO EVALUATION
  • Life Sciences & Biomedicine
  • MEMANTINE
  • MULTIFUNCTIONAL AGENTS
  • Physical Sciences
  • SITE
  • Science & Technology
  • TACRINE CONGENERS
  • acetylcholinesterase
  • amantadine
  • butyrylcholinesterase
  • inhibitor

Digital Object Identifier (DOI)

publisher

  • MDPI

start page

  • 2397

end page

  • 2418

volume

  • 18

issue

  • 2